US Bancorp
LAB icon

US Bancorp’s Standard BioTools LAB Stock Holding History

US Bancorp’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-229
Closed -$293 – 4261
2025
Q4 		$293 Hold
229
– – ﹤0.01% 3955
2025
Q3 		$298 Hold
229
– – ﹤0.01% 3910
2025
Q2 		$275 Buy
+229
New +$254 ﹤0.01% 4049
2024
Q4 		– Sell
-116
Closed -$224 – 4222
2024
Q3 		$224 Buy
+116
New +$227 ﹤0.01% 4007
2022
Q1 		– Sell
-352
Closed -$1K – 4138
2021
Q4 		$1K Buy
+352
New +$1.65K ﹤0.01% 3994
2021
Q3 		– Sell
-500
Closed -$3K – 4137
2021
Q2 		$3K Hold
500
– – ﹤0.01% 3735
2021
Q1 		$2K Buy
+500
New +$2.75K ﹤0.01% 3710
2020
Q1 		– Sell
-207
Closed -$1K – 3737
2019
Q4 		$1K Buy
+207
New +$728 ﹤0.01% 3579
2016
Q1 		– Sell
-303
Closed -$3K – 3597
2015
Q4 		$3K Hold
303
– – ﹤0.01% 3358
2015
Q3 		$2K Sell
303
-2,254
-88% -$35.5K ﹤0.01% 3429
2015
Q2 		$61K Buy
2,557
+665
+35% +$21K ﹤0.01% 2427
2015
Q1 		$79K Sell
1,892
-954
-34% -$37.7K ﹤0.01% 2298
2014
Q4 		$96K Buy
2,846
+1,767
+164% +$50K ﹤0.01% 2163
2014
Q3 		$26K Sell
1,079
-164
-13% -$4.61K ﹤0.01% 2769
2014
Q2 		$37K Buy
1,243
+733
+144% +$23.5K ﹤0.01% 2619
2014
Q1 		$22K Sell
510
-372
-42% -$16.4K ﹤0.01% 2802
2013
Q4 		$34K Buy
+882
New +$26K ﹤0.01% 2579

Other funds holding LAB

CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
MCO
MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HBWM
Hollow Brook Wealth Management Katonah, New York $392M AUM 36.68% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

US Bancorp's LAB Position: Q1 2026 in Review

US Bancorp sold out of Standard BioTools (LAB) in Q1 2026, closing a stake of 229 shares — an estimated $293 sold.

US Bancorp first reported a position in LAB in Q4 2013 and held it in 17 quarters. The position peaked at $96K in Q4 2014. 155 funds tracked by Wall St. Rank hold LAB as of Q1 2026.

  • US Bancorp reported no remaining Standard BioTools position as of Q1 2026 after selling out during the quarter.
  • US Bancorp sold 229 Standard BioTools shares in Q1 2026, an estimated $293.
  • US Bancorp first reported a position in Standard BioTools in Q4 2013 and held it in 17 quarters.
  • US Bancorp's Standard BioTools position peaked at $96K in Q4 2014.
  • 155 funds tracked by Wall St. Rank held Standard BioTools as of Q1 2026.

Based on US Bancorp's 13F filing for Q1 2026, filed 15 May 2026.